Cutera (NASDAQ:CUTR) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a note issued to investors on Tuesday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Stock Performance

CUTR stock opened at $0.48 on Tuesday. The company has a market capitalization of $9.63 million, a P/E ratio of -0.07 and a beta of 1.31. The company has a fifty day moving average price of $0.39 and a 200-day moving average price of $0.72. Cutera has a 52-week low of $0.28 and a 52-week high of $3.70.

Institutional Investors Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Squarepoint Ops LLC increased its stake in Cutera, Inc. (NASDAQ:CUTR) by 164.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 113,964 shares of the medical device company’s stock after acquiring an additional 70,870 shares during the quarter. Squarepoint Ops LLC owned about 0.57% of Cutera worth $172,000 at the end of the most recent reporting period. 90.70% of the stock is currently owned by hedge funds and other institutional investors.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.